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ABSTRACT
Fibroadenoma is the most common benign tumor of the breast in young females. Breast cancer arising within a fibroadenoma is a rare phenomenon. The 
incidence of carcinoma within a fibroadenoma is reported to be between 0.1% and 0.3% in a screened population, with a peak age of occurrence between 
the 4th and 5th decade. We present a case of 29-year-old female with ductal carcinoma in situ in a background of fibroadenoma. There is a low percentage of 
fibroadenomas harboring carcinoma; however, all breast lumps should be seriously managed; extirpation and histological examination is recommended.
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INTRODUCTION
Fibroadenoma is the most common benign tumor of the breast in 
young females, which is treated with lumpectomy. It is more common in 
women during the 2nd–3rd decade of life [1].
Fibroadenoma is a benign tumor composed of stromal and epithelial 
components that display a wide variety of proliferative and non-
proliferative histologic changes [1]. Although fibroadenoma is a benign 
tumor, there has been evidence of increased risk of association with 
invasive breast cancer [2,3].
It is difficult to assess the carcinoma component in fibroadenoma, 
because their features are similar to fibroadenoma [4]. They are 
found to contain both in situ and invasive malignancies. Furthermore, 
progression of the epithelial component to carcinoma in situ (CIS) 
and invasive carcinoma has been documented in the literature [3,4]. 
Cheatle and Cutler were the first to describe carcinoma arising in a 
fibroadenoma in 1939 [5].
The risk of developing carcinoma in fibroadenoma was common 
in complex fibroadenomas and during the 4th–5th decade of life [2]. 
However, the transformation of benign fibroadenoma to carcinoma 
is rare. Ductal CIS (DCIS) in a fibroadenoma not only changes the 
treatment modality but also the prognosis. We hereby report a rare case 
of DCIS arising from multiple fibroadenomas in a young female.
CASE REPORT
A 29-year-old female presented to the hospital with multiple lumps 
in both breasts for 8 years. There was no family history of breast 
carcinoma.
On clinical examination, there were multiple lumps in both the breasts, 
eight on the right side and four on the left side. The lumps had well-
defined margins with smooth surface. They were firm in consistency 
and freely mobile. There was no tenderness, local rise in temperature, 
nipple discharge, or palpable axillary lymph nodes. Routine 
blood investigations were normal. A clinical diagnosis of multiple 
fibroadenomas was made.
Ultrasound of both the breasts revealed well-circumscribed, 
homogenous, and hypoechoic lesions. The features were suggestive of 
fibroadenoma of bilateral breasts (Fig. 1).
Fine-needle aspiration cytology was done and showed multiple cohesive 
clusters of branching papillary fronds of benign ductal epithelium 
suggestive of fibroadenoma (Fig. 2).
Based on the imaging and cytology reports, she underwent lumpectomy 
at Kasturba Hospital, Manipal, and the excised tissue was subjected for 
histopathological examination. Grossly, multiple, well-circumscribed, 
and encapsulated masses with the largest measuring 4 cm×2 cm×2.5 cm 
were noted (Fig. 3).
On cut section, they were homogenous, gray-white with slit-like spaces. 
On microscopy, benign compressed ducts with pericanalicular and 
intracanalicular proliferation were predominantly seen suggestive 
of fibroadenoma along with one lump showing nests of cells having 
pleomorphic nuclei, prominent nucleoli with atypical mitosis, and 
cribriform pattern suggestive of DCIS (Figs. 4 and 5).
The patient was healthy and there was no evidence of recurrent disease 
12 months after the excision.
DISCUSSION
Fibroadenomas are the most common benign tumors of the breast. 
It mostly affects younger age females with peak incidence during 
the second to third decade of life. In our case, the age of the patient 
was 29 years who presented with multiple, mobile lumps in both the 
breasts and was diagnosed as fibroadenoma. These tumors are benign 
and carcinoma arising from fibroadenoma is a rare phenomenon. The 
frequency of carcinoma inside a fibroadenoma is 0.1–0.3%, the median 
age for breast cancer was 61 years of age and was extremely rare in 
women <30 years of age [2-4].
Breast is a dynamic organ which undergoes physiological changes 
during puberty, menstruation, pregnancy, and lactation [6].
Triple test is done to evaluate breast lesions such as clinical examination, 
fine-needle aspiration cytology, and mammography [1,7]. There are 
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no clinical criteria to suggest malignant focus has developed within a 
fibroadenoma [8]. The most common presenting symptom is a palpable 
mobile mass, occurring in 66% of patients, with a diameter varying 
from 0.5 cm to 10 cm [9,10]. Fondo et al. reported microcalcifications 
inside the tumor in 4 of 9 cases. There were no such features in our 
study [11].
On sonography, fibroadenoma is an isoechoic or minimally hypoechoic, 
solid nodule that is generally associated with homogenous texture. 
Sonography findings are more useful than mammogram [7].
Fibroadenomas show various features such as proliferative epithelial 
changes such as hyperplasia, calcification, squamous metaplasia, 
adenosis, papilloma, CIS, and invasive carcinoma [1,12]. Fibroadenomas 
are classified as simple or complex. Complex fibroadenomas show 
many variations compared to simple fibroadenomas because of the 
presence of cysts (>3 mm), sclerosing adenosis, epithelial calcifications, 
or papillary apocrine changes. This can lead to higher risk for 
transformation into malignancy [13].
Complex fibroadenomas and proliferative disease adjacent to 
fibroadenoma are associated with a slight increase in the risk of breast 
cancer. 66% of carcinomas inside fibroadenoma are lobular and 33% 
are ductal or mixed ductal and lobular; lobular CIS and DCIS have same 
frequency [14,15]. Pre-operative diagnosis of carcinoma arising from 
these lesions is difficult because of the close resemblance of presenting 
features with benign fibroadenoma [12-18].
Whether fibroadenoma is a risk factor for breast cancer remains 
uncertain, and several reports have discussed this phenomenon. Dupont 
et al. reported that the risk of invasive breast cancer was 2.17 times 
Fig. 1: Ultrasonography - hypoechoic lesion
Fig. 2: Fine-needle aspiration cytology - cohesive clusters with 
branching papillary fronds
Fig. 3: Gross-multiple, well-circumscribed, encapsulated masses
Fig. 4: H and E - fibroadenoma with compressed ducts
Fig. 5: H and E malignant cellular proliferation with comedo 
necrosis suggestive of ductal carcinoma in situ
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higher in patients with fibroadenoma and increased to 3.10 times higher 
in complex fibroadenomas. The risk of malignant change persisted even 
20 years after the diagnosis of fibroadenoma. Other studies also provide 
strong evidence that fibroadenoma with hyperplasia is associated with 
an increased risk of breast cancer [19,20].
Many criteria are followed to diagnose carcinoma in fibroadenoma. 
Diagnostic criteria of DCIS within fibroadenoma require showing at 




The older patient with a positive family history of breast carcinoma 
may have more clinical importance than younger women. The 
environmental risk factors are associated with breast carcinoma such 
as unhealthy dietary habits, obesity, use of unsafe cosmetics, estrogen 
exposure, hormone replacement therapy, use of oral contraceptives, 
and smoking [21].
Excision with breast conservative surgery done for in situ carcinoma 
arising in fibroadenoma. Radiotherapy and chemotherapy are usually 
not required but advised in advanced cases with axillary lymph node 
involvement. Early detection has good prognosis.
CONCLUSION
Carcinomas are common in complex fibroadenoma, in patients with 
family history of the breast carcinoma and the risk of carcinoma 
increases as age increases. Hence, all cases presenting in old age and 
positive family history are screened for any possibility of carcinoma. 
In the present study, it was a younger female, radiology and cytology 
revealed multiple fibroadenomas, but carcinoma was detected 
incidentally on histological examination. Hence, there is a need for 
extensive sampling to prevent false-negative diagnosis, especially in 
younger women.
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